NCT00595049View on ClinicalTrials.gov

Pulmonary Artery Remodelling With Bosentan

PHASE4CompletedINTERVENTIONAL

Enrollment

11

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

June 30, 2010

Conditions

Hypertension, Pulmonary

Interventions

DRUG

bosentan

Bosentan 62.5 mg bid for 4 weeks, then 125 mg bid

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Actelion

INDUSTRY